Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Pharmacy | 6 | 2024 | 73 | 1.370 |
Why?
|
| Students, Pharmacy | 5 | 2024 | 73 | 1.260 |
Why?
|
| Pseudomonas aeruginosa | 3 | 2006 | 34 | 0.740 |
Why?
|
| Anti-Bacterial Agents | 4 | 2014 | 183 | 0.570 |
Why?
|
| Critical Care | 1 | 2016 | 12 | 0.540 |
Why?
|
| Faculty | 2 | 2013 | 15 | 0.500 |
Why?
|
| Ceftazidime | 1 | 2015 | 9 | 0.500 |
Why?
|
| Status Epilepticus | 1 | 2015 | 14 | 0.500 |
Why?
|
| Educational Measurement | 4 | 2024 | 49 | 0.440 |
Why?
|
| Leadership | 2 | 2024 | 15 | 0.370 |
Why?
|
| Humans | 15 | 2024 | 5485 | 0.350 |
Why?
|
| Candidiasis, Invasive | 1 | 2010 | 3 | 0.340 |
Why?
|
| Critical Illness | 1 | 2010 | 6 | 0.340 |
Why?
|
| Intensive Care Units | 1 | 2010 | 17 | 0.340 |
Why?
|
| Antifungal Agents | 1 | 2010 | 18 | 0.340 |
Why?
|
| Staphylococcus aureus | 3 | 2006 | 20 | 0.330 |
Why?
|
| Microbial Sensitivity Tests | 6 | 2014 | 99 | 0.310 |
Why?
|
| Gentamicins | 1 | 2006 | 3 | 0.270 |
Why?
|
| Thienamycins | 1 | 2005 | 6 | 0.260 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2005 | 16 | 0.250 |
Why?
|
| beta-Lactams | 1 | 2005 | 12 | 0.250 |
Why?
|
| Emotional Intelligence | 1 | 2024 | 15 | 0.230 |
Why?
|
| Academic Performance | 1 | 2024 | 20 | 0.230 |
Why?
|
| Curriculum | 3 | 2024 | 50 | 0.220 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2003 | 5 | 0.210 |
Why?
|
| Streptococcal Infections | 1 | 2003 | 4 | 0.210 |
Why?
|
| Staphylococcal Infections | 1 | 2003 | 8 | 0.210 |
Why?
|
| Male | 5 | 2024 | 2770 | 0.190 |
Why?
|
| Acetamides | 2 | 2014 | 2 | 0.180 |
Why?
|
| Oxazolidinones | 2 | 2014 | 6 | 0.180 |
Why?
|
| Absenteeism | 1 | 2020 | 2 | 0.170 |
Why?
|
| Vancomycin | 2 | 2014 | 28 | 0.170 |
Why?
|
| Teaching | 1 | 2020 | 13 | 0.170 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 22 | 0.170 |
Why?
|
| Models, Psychological | 1 | 2020 | 32 | 0.170 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 53 | 0.170 |
Why?
|
| Young Adult | 3 | 2024 | 852 | 0.150 |
Why?
|
| Gene-Environment Interaction | 1 | 2017 | 4 | 0.140 |
Why?
|
| Bacteremia | 2 | 2015 | 10 | 0.140 |
Why?
|
| Online Systems | 1 | 2016 | 4 | 0.140 |
Why?
|
| Problem-Based Learning | 1 | 2016 | 6 | 0.140 |
Why?
|
| Faculty, Pharmacy | 1 | 2016 | 11 | 0.140 |
Why?
|
| Internet | 1 | 2016 | 35 | 0.130 |
Why?
|
| Adult | 3 | 2024 | 1687 | 0.130 |
Why?
|
| Myoclonus | 1 | 2015 | 1 | 0.130 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 7 | 0.130 |
Why?
|
| Drug Resistance, Multiple | 1 | 2015 | 9 | 0.130 |
Why?
|
| Female | 4 | 2024 | 2816 | 0.120 |
Why?
|
| Gram-Positive Bacteria | 1 | 2014 | 3 | 0.120 |
Why?
|
| Models, Biological | 2 | 2006 | 131 | 0.110 |
Why?
|
| Aminoglycosides | 1 | 2014 | 17 | 0.110 |
Why?
|
| Data Collection | 1 | 2013 | 15 | 0.110 |
Why?
|
| Age Factors | 1 | 2013 | 75 | 0.100 |
Why?
|
| Sex Factors | 1 | 2013 | 81 | 0.100 |
Why?
|
| Neoplasms | 1 | 2014 | 99 | 0.100 |
Why?
|
| Middle Aged | 1 | 2015 | 1100 | 0.090 |
Why?
|
| Professional Practice | 1 | 2010 | 2 | 0.090 |
Why?
|
| Animals | 2 | 2010 | 1817 | 0.090 |
Why?
|
| Drug Resistance, Fungal | 1 | 2010 | 3 | 0.090 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2010 | 6 | 0.090 |
Why?
|
| Colony Count, Microbial | 2 | 2006 | 13 | 0.080 |
Why?
|
| Pharmacists | 1 | 2010 | 41 | 0.080 |
Why?
|
| Peer Review | 1 | 2008 | 2 | 0.080 |
Why?
|
| Publications | 1 | 2008 | 2 | 0.080 |
Why?
|
| Communicable Diseases | 1 | 2008 | 6 | 0.080 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 16 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 53 | 0.070 |
Why?
|
| Kinetics | 1 | 2006 | 79 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2006 | 70 | 0.060 |
Why?
|
| Time Factors | 1 | 2006 | 176 | 0.060 |
Why?
|
| Porins | 1 | 2005 | 4 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 3 | 0.060 |
Why?
|
| beta-Lactam Resistance | 1 | 2005 | 6 | 0.060 |
Why?
|
| Catheterization, Central Venous | 1 | 2005 | 1 | 0.060 |
Why?
|
| Gram-Positive Cocci | 1 | 2005 | 1 | 0.060 |
Why?
|
| Cross Infection | 1 | 2005 | 19 | 0.060 |
Why?
|
| Pseudomonas Infections | 1 | 2005 | 19 | 0.060 |
Why?
|
| Biofilms | 1 | 2005 | 27 | 0.060 |
Why?
|
| Social Responsibility | 1 | 2024 | 9 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 350 | 0.060 |
Why?
|
| Schools, Pharmacy | 2 | 2017 | 24 | 0.060 |
Why?
|
| Adjuvants, Immunologic | 1 | 2003 | 5 | 0.050 |
Why?
|
| Virulence | 1 | 2003 | 6 | 0.050 |
Why?
|
| Streptococcus pyogenes | 1 | 2003 | 4 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2024 | 382 | 0.050 |
Why?
|
| Linezolid | 2 | 2014 | 2 | 0.040 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2014 | 4 | 0.040 |
Why?
|
| Behavior Control | 1 | 2020 | 2 | 0.040 |
Why?
|
| Choice Behavior | 1 | 2020 | 11 | 0.040 |
Why?
|
| Social Behavior | 1 | 2020 | 26 | 0.040 |
Why?
|
| Motivation | 1 | 2020 | 70 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2019 | 8 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 7 | 0.030 |
Why?
|
| Pharmacy Administration | 1 | 2010 | 1 | 0.020 |
Why?
|
| Societies, Pharmaceutical | 1 | 2010 | 1 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2010 | 4 | 0.020 |
Why?
|
| Professional Role | 1 | 2010 | 4 | 0.020 |
Why?
|
| Pharmaceutical Services | 1 | 2010 | 18 | 0.020 |
Why?
|
| Periodicals as Topic | 1 | 2008 | 9 | 0.020 |
Why?
|
| Enterococcus faecium | 1 | 2005 | 1 | 0.020 |
Why?
|
| Staphylococcus epidermidis | 1 | 2005 | 2 | 0.020 |
Why?
|